Cibus nets $70 mln Series C
Cibus, a provider of gene editing technologies for directed mutagenesis, has raised $70 million in Series C funding. Fidelity Management and Research Company led the round with participation from other investors that included Alexandria Venture Investments and Cormorant Asset Management.
28 June 2018•1 min read
